Needle tract seeding after percutaneous biopsy of sarcoma: Risk/benefit considerations

Needle tract seeding after percutaneous biopsy of sarcoma: Risk/benefit considerations
Needle tract seeding after percutaneous biopsy of sarcomas is a common fear but is based on case reports or series mainly. This review summarizes current data on needle tract seeding after percutaneous biopsy.
Needle tract seeding after percutaneous biopsy of sarcomas with recurrence of the tumor was very low in available data (below 1%) despite significantly higher prevalence of malignant cells in excised needle tracts (4 to 22%).

Joomla! Debug Console

Session

Profile Information

Memory Usage

Database Queries